NCT03003104View on ClinicalTrials.gov

DMT210 Topical Gel in the Treatment of Acne Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 30, 2017

Study Completion Date

August 30, 2017

Conditions
Acne Rosacea
Interventions
DRUG

DMT210 Topical Gel 5%

OTHER

Vehicle Control

Trial Locations (9)

Unknown

Dermata Investigational Site, San Diego

Dermata Investigational Site, Miami

Dermata Investigational Site, Fridley

Dermata Investigational Site, Omaha

Dermata Investigational Site, High Point

Dermata Investigational Site, Broomall

Dermata Investigational Site, Nashville

Dermata Investigational Site, Austin

Dermata Investigational Site, Norfolk

Sponsors
All Listed Sponsors
lead

Dermata Therapeutics

INDUSTRY

NCT03003104 - DMT210 Topical Gel in the Treatment of Acne Rosacea | Biotech Hunter | Biotech Hunter